PlainRecalls
FDA Drug Moderate Class II Terminated

Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-046-15

Reported: August 16, 2017 Initiated: July 14, 2017 #D-1078-2017

Product Description

Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-046-15

Reason for Recall

Lack of Sterility Assurance.

Details

Recalling Firm
Cantrell Drug Company
Units Affected
120856 syringes
Distribution
Nationwide within the US
Location
Little Rock, AR

Frequently Asked Questions

What product was recalled?
Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-046-15. Recalled by Cantrell Drug Company. Units affected: 120856 syringes.
Why was this product recalled?
Lack of Sterility Assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 16, 2017. Severity: Moderate. Recall number: D-1078-2017.